Trade Asensus Surgical, Inc. - ASXC CFD
Add to favourite- Summary
- Historical Data
Spread | 0.0037 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 0.3366 |
Open | 0.3364 |
1-Year Change | -32.54% |
Day's Range | 0.3364 - 0.3373 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Jul 25, 2024 | 0.3361 | 0.0028 | 0.84% | 0.3333 | 0.3373 | 0.3302 |
Jul 24, 2024 | 0.3353 | -0.0020 | -0.59% | 0.3373 | 0.3380 | 0.3353 |
Jul 23, 2024 | 0.3363 | 0.0020 | 0.60% | 0.3343 | 0.3386 | 0.3343 |
Jul 22, 2024 | 0.3364 | 0.0004 | 0.12% | 0.3360 | 0.3383 | 0.3330 |
Jul 19, 2024 | 0.3353 | 0.0011 | 0.33% | 0.3342 | 0.3387 | 0.3340 |
Jul 18, 2024 | 0.3353 | -0.0023 | -0.68% | 0.3376 | 0.3379 | 0.3343 |
Jul 17, 2024 | 0.3363 | 0.0003 | 0.09% | 0.3360 | 0.3383 | 0.3360 |
Jul 16, 2024 | 0.3379 | 0.0015 | 0.45% | 0.3364 | 0.3387 | 0.3363 |
Jul 15, 2024 | 0.3361 | 0.0009 | 0.27% | 0.3352 | 0.3376 | 0.3343 |
Jul 12, 2024 | 0.3370 | 0.0028 | 0.84% | 0.3342 | 0.3379 | 0.3280 |
Jul 11, 2024 | 0.3372 | 0.0048 | 1.44% | 0.3324 | 0.3376 | 0.3303 |
Jul 10, 2024 | 0.3313 | -0.0029 | -0.87% | 0.3342 | 0.3362 | 0.3263 |
Jul 9, 2024 | 0.3329 | -0.0016 | -0.48% | 0.3345 | 0.3365 | 0.3323 |
Jul 8, 2024 | 0.3324 | -0.0018 | -0.54% | 0.3342 | 0.3368 | 0.3310 |
Jul 5, 2024 | 0.3323 | 0.0025 | 0.76% | 0.3298 | 0.3365 | 0.3296 |
Jul 3, 2024 | 0.3309 | 0.0029 | 0.88% | 0.3280 | 0.3351 | 0.3261 |
Jul 2, 2024 | 0.3336 | 0.0072 | 2.21% | 0.3264 | 0.3341 | 0.3264 |
Jul 1, 2024 | 0.3313 | 0.0063 | 1.94% | 0.3250 | 0.3341 | 0.3250 |
Jun 28, 2024 | 0.3306 | 0.0064 | 1.97% | 0.3242 | 0.3339 | 0.3242 |
Jun 27, 2024 | 0.3274 | 0.0006 | 0.18% | 0.3268 | 0.3315 | 0.3206 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Asensus Surgical, Inc. Company profile
Asensus Surgical (ASXC) is a medical device company that engages in digitising the interface between the surgeon and the patient to improve minimally invasive surgery (MIS).
Founded in 2006, Asensus is headquartered in Durham, North Carolina. It pioneers a new era of performance-guided surgery, using advanced capabilities, like machine vision, augmented intelligence, connectivity and robotics in laparoscopy.
Asensus has built the foundation of Digital Laparoscopy with the help of its Senhance Surgical System powered by the Intelligent Surgical Unit (ISU) to address clinical, cognitive and economic shortcomings in surgery.
The Senhance Surgical System is a multi-port robotic system that provides enhanced control with surgeon eye-tracking camera control & 3D (three dimensional) HD (high definition) vision and enhances precision through tremor filtrations and robotic stabilisation. Additionally, surgeons can have enhanced focus during surgery through Asensus’s optimised ergonomics and the sense of touch (haptics).
The surgical device that consists of a robotic instrument and a camera for laparoscopic procedures is considered to be the smallest instrument offered in robotics, leading to smaller incisions than traditional robotic surgery. Asensus’ Senhance ultrasonic system is an advanced energy device to deliver controlled energy to ligate and divide tissue.
Asensus Surgical previously developed the SPIDER device and the SurgiBot System. It changed its name from TransEnterix in February 2021. The company went public as TransEnterix in May 2014. It trades on the NYSE American under the ticker ‘ASXC’.
Industry: | Medical Equipment, Supplies & Distribution (NEC) |
1 Tw Alexander Drive
Suite 160
DURHAM
NORTH CAROLINA 27703
US
News
![](https://img.capital.com/imgs/articles/192x130x1/Risk-Management-in-Trading.png)
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024![](https://img.capital.com/imgs/articles/192x130x1/ECB_0.png)
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024![](https://img.capital.com/imgs/articles/192x130x1/risk_2_1_optimized_450_1.png)
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024![](https://img.capital.com/imgs/articles/192x130x1/Stock-1-_1.png)
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024![](https://img.capital.com/imgs/articles/192x130x1/ETF-1-_0.png)
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024![Lloyds share price forecast: An attractive dividend stock? Lloyds share price forecast: An attractive dividend stock?](https://img.capital.com/imgs/articles/192x130x1/shutterstock_536730610_0.jpg)
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024![](https://img.capital.com/imgs/articles/192x130x1/RBNZ.png)
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com